Literature DB >> 18707036

Hepatocyte growth factor improves survival after partial hepatectomy in cirrhotic rats suppressing apoptosis of hepatocytes.

Masayuki Nishino1, Yuji Iimuro, Takahiro Ueki, Tadamichi Hirano, Jiro Fujimoto.   

Abstract

BACKGROUND: Liver failure after hepatic resection is still a critical issue in the treatment of hepatic tumors in patients with liver cirrhosis. In the current study, the effect of hepatocyte growth factor (HGF) gene transfer, which is a multipotent growth factor, was examined in rats with liver cirrhosis that underwent 2/3 partial hepatectomy (PH).
METHODS: Rats were treated with 1 mL of 1% dimethylnitrosoamine (DMN) 3 consecutive days per week for 4 weeks and then received a 2/3 PH. Three days before the PH, human HGF gene plasmid (20 microg) encapsulated in hemagglutinating virus of Japan (HVJ)-liposome was administered through a direct injection in the portal vein. Control cirrhotic rats received empty HVJ-liposome in the same manner.
RESULTS: HGF gene transfer significantly improved survival after PH in the cirrhotic rats, and it stimulated BrdU uptake in hepatocytes. Although the HGF gene transfer did not change the liver regeneration rate after PH, it suppressed hepatocyte apoptosis and upregulated an antiapoptotic protein, Bcl-xl, but it did not affect the expression of Bax, which is a proapoptotic protein.
CONCLUSION: HGF gene transfer to cirrhotic livers improves liver failure-associated death after PH upregulating expression of an antiapoptotic protein, Bcl-xl.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18707036     DOI: 10.1016/j.surg.2008.04.011

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

Review 1.  Gene therapy for liver regeneration: experimental studies and prospects for clinical trials.

Authors:  Hussein-M Atta
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

2.  Cultivating hepatocytes on printed arrays of HGF and BMP7 to characterize protective effects of these growth factors during in vitro alcohol injury.

Authors:  Caroline N Jones; Nazgul Tuleuova; Ji Youn Lee; Erlan Ramanculov; A Hari Reddi; Mark A Zern; Alexander Revzin
Journal:  Biomaterials       Date:  2010-05-21       Impact factor: 12.479

3.  Stimulation of oval cell and hepatocyte proliferation by exogenous bombesin and neurotensin in partially hepatectomized rats.

Authors:  Stelios F Assimakopoulos; Athanassios C Tsamandas; Ilias H Alexandris; Christos Georgiou; Constantine E Vagianos; Chrisoula D Scopa
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

4.  Hepatocyte growth factor-modified mesenchymal stem cells improve ischemia/reperfusion-induced acute lung injury in rats.

Authors:  S Chen; X Chen; X Wu; S Wei; W Han; J Lin; M Kang; L Chen
Journal:  Gene Ther       Date:  2016-08-24       Impact factor: 5.250

5.  Serum thymosin beta4 levels in patients with hepatitis B virus-related liver failure.

Authors:  Tao Han; Ying Liu; Huan Liu; Zheng-Yan Zhu; Yan Li; Shi-Xiang Xiao; Zhen Guo; Zhen-Gang Zhao
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

6.  The identification of stem cells in human liver diseases and hepatocellular carcinoma.

Authors:  Joan Oliva; Barbara A French; X Qing; Samuel W French
Journal:  Exp Mol Pathol       Date:  2010-01-18       Impact factor: 3.362

7.  The phosphodiesterase 3 inhibitor cilostazol does not stimulate growth of colorectal liver metastases after major hepatectomy.

Authors:  Moritz J Strowitzki; Stefan Dold; Maximilian von Heesen; Christina Körbel; Claudia Scheuer; Mohammed R Moussavian; Martin K Schilling; Otto Kollmar; Michael D Menger
Journal:  Clin Exp Metastasis       Date:  2014-07-23       Impact factor: 5.150

8.  Local control of hepatic phenotype with growth factor-encoded surfaces.

Authors:  Dipali Patel; Amranul Haque; Caroline N Jones; Nazgul Tuleouva; Elena Foster; Tam Vu; A Hari Reddi; Alexander Revzin
Journal:  Integr Biol (Camb)       Date:  2014-01       Impact factor: 2.192

9.  Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression.

Authors:  Hussein Atta; Mahmoud El-Rehany; Olfat Hammam; Hend Abdel-Ghany; Maggie Ramzy; Martin Roderfeld; Elke Roeb; Ayman Al-Hendy; Salama Abdel Raheim; Hatem Allam; Heba Marey
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

10.  Therapeutic potentials occurring during the early differentiation process of mesenchymal stem cells in a rats model with thioacetamide-induced liver fibrosis.

Authors:  Sang-Tae Choi; Shin Hwang; Hea-Nam Hong; You-Jin Won; Chul-Soo Ahn; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.